This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Adaptimmune Therapeutics (ADAP) upgraded to Buy from Neutral at Guggenheim; tgt $5
> Edison (EIX) upgraded to Buy from Neutral at UBS; tgt raised to $75
> Enfusion (ENFN) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt lowered to $12
Downgrades:
> Ally Financial (ALLY) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $33
> American Homes 4 Rent (AMH) downgraded to Hold from Buy at Jefferies; tgt lowered to $32
> Apple (AAPL) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $140
> Azenta (AZTA) downgraded to In-line from Outperform at Evercore ISI; tgt raised to $62
> Capital One (COF) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $119
> CubeSmart (CUBE) downgraded to Hold from Buy at Jefferies; tgt lowered to $41
> Entergy (ETR) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $119
> Fate Therapeutics (FATE) downgraded to Neutral from Buy at Guggenheim
> Fresenius Medical (FMS) downgraded to Underperform from Buy at Jefferies; tgt lowered to $11.70
> Traeger (COOK) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3
Others:
> General Mills (GIS) initiated with an Equal Weight at Wells Fargo
> Hershey Foods (HSY) initiated with an Underweight at Wells Fargo
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
